Oarsman Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $565K | Sell |
23,471
-549
| -2% | -$14.4K | 0.06% | 132 |
|
|
2026
Q1 | $674K | Sell |
24,020
-6,650
| -22% | -$177K | 0.08% | 118 |
|
|
2025
Q4 | $764K | Sell |
30,670
-1,047
| -3% | -$26.4K | 0.1% | 113 |
|
|
2025
Q3 | $808K | Sell |
31,717
-1,865
| -6% | -$46K | 0.11% | 104 |
|
|
2025
Q2 | $814K | Sell |
33,582
-1,022
| -3% | -$23.8K | 0.13% | 108 |
|
|
2025
Q1 | $877K | Buy |
34,604
+1,035
| +3% | +$27.1K | 0.16% | 101 |
|
|
2024
Q4 | $891K | Sell |
33,569
-959
| -3% | -$26K | 0.16% | 97 |
|
|
2024
Q3 | $999K | Buy |
34,528
+296
| +0.9% | +$8.63K | 0.18% | 92 |
|
|
2024
Q2 | $958K | Buy |
34,232
+120
| +0.4% | +$3.3K | 0.21% | 92 |
|
|
2024
Q1 | $947K | Buy |
34,112
+20,567
| +152% | +$571K | 0.23% | 93 |
|
|
2023
Q4 | $390K | Sell |
13,545
-966
| -7% | -$29.2K | 0.1% | 147 |
|
|
2023
Q3 | $481K | Buy |
14,511
+2,170
| +18% | +$76.7K | 0.2% | 102 |
|
|
2023
Q2 | $453K | Sell |
12,341
-1,001
| -8% | -$39K | 0.2% | 108 |
|
|
2023
Q1 | $544K | Sell |
13,342
-341
| -2% | -$14.7K | 0.25% | 89 |
|
|
2022
Q4 | $701K | Sell |
13,683
-1,925
| -12% | -$92.3K | 0.36% | 74 |
|
|
2022
Q3 | $683K | Buy |
15,608
+1,208
| +8% | +$58.7K | 0.37% | 79 |
|
|
2022
Q2 | $755K | Sell |
14,400
-2,446
| -15% | -$125K | 0.37% | 79 |
|
|
2022
Q1 | $872K | Sell |
16,846
-4,809
| -22% | -$250K | 0.34% | 83 |
|
|
2021
Q4 | $1.28M | Sell |
21,655
-2,679
| -11% | -$133K | 0.5% | 64 |
|
|
2021
Q3 | $1.05M | Sell |
24,334
-1,986
| -8% | -$88K | 0.42% | 76 |
|
|
2021
Q2 | $1.03M | Buy |
26,320
+234
| +0.9% | +$9.1K | 0.41% | 79 |
|
|
2021
Q1 | $945K | Sell |
26,086
-3,067
| -11% | -$109K | 0.41% | 80 |
|
|
2020
Q4 | $1.07M | Sell |
29,153
-2,063
| -7% | -$75.7K | 0.42% | 70 |
|
|
2020
Q3 | $1.09M | Sell |
31,216
-229
| -0.7% | -$8.03K | 0.49% | 59 |
|
|
2020
Q2 | $976K | Buy |
31,445
+5,415
| +21% | +$184K | 0.48% | 61 |
|
|
2020
Q1 | $806K | Sell |
26,030
-5,952
| -19% | -$203K | 0.74% | 44 |
|
|
2019
Q4 | $1.19M | Buy |
31,982
+153
| +0.5% | +$5.45K | 0.54% | 60 |
|
|
2019
Q3 | $1.08M | Sell |
31,829
-90
| -0.3% | -$3.27K | 0.52% | 66 |
|
|
2019
Q2 | $1.31M | Sell |
31,919
-57
| -0.2% | -$2.26K | 0.59% | 57 |
|
|
2019
Q1 | $1.29M | Sell |
31,976
-709
| -2% | -$28.4K | 0.61% | 59 |
|
|
2018
Q4 | $1.35M | Sell |
32,685
-1,332
| -4% | -$55.3K | 0.69% | 49 |
|
|
2018
Q3 | $1.42M | Sell |
34,017
-690
| -2% | -$26.6K | 0.57% | 59 |
|
|
2018
Q2 | $1.2M | Sell |
34,707
-1,502
| -4% | -$51.3K | 0.54% | 66 |
|
|
2018
Q1 | $1.22M | Sell |
36,209
-1,595
| -4% | -$54.8K | 0.55% | 59 |
|
|
2017
Q4 | $1.3M | Sell |
37,804
-2,018
| -5% | -$68.8K | 0.56% | 58 |
|
|
2017
Q3 | $1.35M | Sell |
39,822
-3,284
| -8% | -$106K | 0.57% | 60 |
|
|
2017
Q2 | $1.37M | Sell |
43,106
-899
| -2% | -$28.4K | 0.63% | 54 |
|
|
2017
Q1 | $1.43M | Buy |
44,005
+18,854
| +75% | +$594K | 0.66% | 50 |
|
|
2016
Q4 | $775K | Sell |
25,151
-24,025
| -49% | -$733K | 0.5% | 70 |
|
|
2016
Q3 | $1.58M | Sell |
49,176
-180
| -0.4% | -$6.02K | 0.81% | 40 |
|
|
2016
Q2 | $1.65M | Sell |
49,356
-594
| -1% | -$19K | 0.86% | 41 |
|
|
2016
Q1 | $1.41M | Sell |
49,950
-1,428
| -3% | -$40.8K | 0.75% | 48 |
|
|
2015
Q4 | $1.57M | Sell |
51,378
-1,842
| -3% | -$57.9K | 0.88% | 39 |
|
|
2015
Q3 | $1.59M | Sell |
53,220
-374
| -0.7% | -$12K | 0.94% | 35 |
|
|
2015
Q2 | $1.71M | Buy |
53,594
+532
| +1% | +$17.3K | 1.16% | 20 |
|
|
2015
Q1 | $1.75M | Buy |
53,062
+142
| +0.3% | +$4.51K | 1.21% | 20 |
|
|
2014
Q4 | $1.56M | Sell |
52,920
-1,572
| -3% | -$45.1K | 1.13% | 26 |
|
|
2014
Q3 | $1.53M | Sell |
54,492
-1,307
| -2% | -$36.7K | 1.13% | 24 |
|
|
2014
Q2 | $1.57M | Buy |
55,799
+3,457
| +7% | +$98.5K | 1.14% | 21 |
|
|
2014
Q1 | $1.59M | Sell |
52,342
-416
| -0.8% | -$12.4K | 1.23% | 16 |
|
|
2013
Q4 | $1.53M | Sell |
52,758
-100
| -0.2% | -$2.91K | 1.23% | 18 |
|
|
2013
Q3 | $1.44M | Buy |
52,858
+1,349
| +3% | +$36.7K | 1.26% | 16 |
|
|
2013
Q2 | $1.37M | Buy |
+51,509
| New | +$1.42M | 1.3% | 17 |
|
Other funds holding PFE
Oarsman Capital's PFE Position: Q2 2026 in Review
Oarsman Capital reduced its Pfizer (PFE) stake by 2.3% in Q2 2026, selling an estimated $14.4K and leaving 23,471 shares worth $565K. The position accounts for 0.06% of the portfolio, ranked #132.
Oarsman Capital first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.75M in Q1 2015. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Oarsman Capital held 23,471 shares of Pfizer worth $565K as of Q2 2026.
- Oarsman Capital sold 549 Pfizer shares in Q2 2026, an estimated $14.4K.
- Pfizer made up 0.06% of Oarsman Capital's portfolio in Q2 2026, its #132 holding.
- Oarsman Capital first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Oarsman Capital's Pfizer position peaked at $1.75M in Q1 2015.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Oarsman Capital's 13F filing for Q2 2026, filed 7 Aug 2026.